HealthcareLatest News

FDA Grants Clearance to the Latest Wireless Medical Biosensor (LP1250) Made by LifeSignals

LifeSignals has announced receiving clearance from U.S Food and Drug Administration (FDA) for its new wireless medical biosensor which is a first of its type ECG Remote Monitoring Patch.

This ECG Remote Monitoring Patch by LifeSignals operates without wires and is helpful to monitor high-risk patients remotely. It allows the doctors to observe Electrocardiography (ECG) and Heart Rate in any medical care facility, hospital, and even at the patient’s home. The data is generated without involving wire through a secure server which received and stores this data.

Also read- Kanye West Presidential Rally Breakdown, Fans Worried for His Mental Health

With this new wireless medical biosensor, doctors and healthcare staff will be able to directly access patient and monitor his condition through a digital screening, allowing continuous monitoring for the risky patients, irrespective of patient’s location.

Surendar Magar is the co-founder and current CEO of the company which is has manufactured this medical sensor.  He says that this clearance is based on the effectiveness and quality of healthcare that this new device will provide.

This biosensor is interoperable allowing all partners to direct towards an easy to wear a device that senses their heart rate and ECG and save this data. Once the patient wears it starts working on data collection, processing, transmitting, and saving through a remote server.

The medical interventions like this wireless medical biosensor will improve in-hospital medical care as well as home care for those who don’t prefer to be at hospitals. Medical professionals are able to assess the patients without a delay and take quick steps to save their life or to make treatment better. This is a more direct approach than in-person visits implying this sensor to be a normal part of new digital therapeutics.

Also read- Oxford-AstraZeneca Candidate is on Road to Successful Coronavirus Vaccine Trial

The new wireless medical biosensor (LP1250) by LifeSignals has various notable features such as;

  • It allows data to be captures through two-channel ECG as well as heart rate monitoring for heart patients.
  • The duration for this data could be up to 72 hours
  • It is single individual use and easy to carry a device that saves time, effort, and money for hospital visits.
  • It is a lightweight tool that is also splash-proof making it comfortable for the patient.
  • It provides the best care even in a noisy and populated home or hospital setup without an interruption in signals.

This clearance from the FDA proceeds ahead to get CE marking as well as approval from HSA. This brand new Wireless Medical Biosensor (LP1250) by LifeSignals will be available in all parts of the world and available for specialized hospital facilities and care units.

Also read-  Asymptomatic Spread of Coronavirus is More Dangerous than Other Deadly Infections


Areeba Hussain

The author is a fulltime medical and healthcare writer. She graduated in Medical Microbiology and Immunology with distinction. Her areas of prime interest are medicine, medical technology, disease awareness, and research analysis. Twitter @Areeba94789300

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


Adblock Detected

Please consider supporting us by disabling your ad blocker